A team of researchers reports that giving tiny roundworms more of a single enzyme, called PCAF-1, made them live longer and stay healthier as they aged1. The worms also responded more strongly to stress and built up fewer of the sticky protein clumps linked to brain diseases, according to the paper1. The work was posted on 12 November 2026 as a preprint, meaning it has not yet been checked by outside experts through peer review1.
The results come from worms only. The study does not test any treatment, drug or supplement in people1.
What happened
The preprint starts from a simple idea. As animals age, their cells get worse at noticing stress and at keeping their proteins in working order, the authors write1. A family of enzymes called lysine acetyltransferases can link stress signals to which genes get switched on, they note, but it was not known whether boosting just one of these enzymes could strengthen stress responses, protect proteins in aging cells and extend healthy life1.
To test this, the team worked with Caenorhabditis elegans, a small roundworm widely used in aging research12. PCAF-1 is the only member of the KAT2 family of these enzymes in the worm1. The researchers raised the amount, or “dosage”, of PCAF-1 in the worms and looked at what changed1.
They report that more PCAF-1 was enough on its own to extend lifespan, preserve “healthspan” (the part of life spent in good health) and reshape which stress-related genes the worms switched on1.
The evidence so far
According to the summary of the paper, the extra PCAF-1 did several things in the worms1:
- Stronger stress responses. The enzyme strengthened the responses cells switch on when they are under stress1.
- Better protein clean-up with age. It lessened the age-related decline in proteasomal degradation, the process in which a cell’s protein-shredding machinery breaks down old or damaged proteins1.
- Fewer protein clumps. In worms engineered to model human neurodegenerative diseases, more PCAF-1 limited protein clumping while the worms kept their ability to move and survive1.
The team also looked at how this might work. They report that PCAF-1 activates DAF-16, a worm protein that controls other genes and is related to a family of proteins called FOXO1. When DAF-16 was missing, the extra PCAF-1 no longer lengthened life and no longer protected against clumping of polyglutamine, a type of protein stretch used in the worm disease models1. In plain terms, the authors say DAF-16 is needed for both effects1.
Finally, the team compared their worm results with data from mammals. Mammals have two related enzymes, KAT2A and KAT2B1. The researchers report that the mammalian versions of genes switched on by PCAF-1 in worms showed up more often than expected among genes whose activity drops when KAT2A and KAT2B are reduced1. They describe this as a sign that the gene program is “conserved”, or shared across species1.
What it does not show yet
Several limits matter for anyone reading about this study.
- Not peer reviewed. The paper is a preprint. Outside scientists have not yet formally checked its methods, data or conclusions1.
- Worms, not people. The lifespan, healthspan and protein-clump results were all measured in C. elegans1. Worms are useful for studying basic biology, but many things that lengthen worm life have not been shown to do the same in mammals.
- The mammal link is about genes, not health. The mammalian part of the study is a comparison of gene activity patterns. The summary does not report any measure of lifespan or health in mammals1.
- Disease models are simplified. The protein-clump results come from worm models of human neurodegenerative diseases, not from patients1.
- No sizes in the summary. The abstract does not say how much longer the worms lived or how many worms were tested, so the size of the effect cannot be judged from it1.
The authors themselves frame KAT2 enzymes as “potential tunable regulators” of protein quality and healthspan during aging, which is a hypothesis for further work rather than a demonstrated way to change human aging1.
Who is behind it
The preprint lists seven authors: A. Sharma, K. Nisaa, L. Blanco-Rodriguez, J. Tachiki, E. Dinneen, M.H. To and C.G. Silva-Garcia1. The material available to Biohack does not state the authors’ institutions, who funded the work, or whether any author has commercial ties to the findings. No company or product is mentioned in the summary1.
How it fits the field
The idea that stress resistance and aging are tied together has a long history in worm research. A 2009 study in the journal Aging Cell noted that work in model organisms has found processes that strongly influence aging, many of which affect resistance to environmental or metabolic stress3. That study looked at SKN-1, another worm protein that controls genes, and found it important for resisting oxidative stress and active in several longevity pathways3. Its authors concluded that, in response to stress, SKN-1 and other regulators “tailor transcription programs to meet the challenge at hand”3.
The new preprint adds a different kind of player to this picture. Instead of a protein that directly switches genes on, PCAF-1 is an enzyme that the authors say links stress signals to gene activity, and they describe their finding as a “previously unrecognized mechanism” by which KAT2 enzymes promote longevity1.
Protein quality control in aging worms is also an active area for other labs. For example, the publication list of the Lapierre Lab includes a 2023 preprint reporting that tagged-for-disposal proteins stay at high levels during aging in C. elegans, and a 2023 paper in iScience on how fat droplets inside cells affect protein quality control and lifespan in the same worm2. The same lab co-wrote a 2019 overview of emerging topics in worm aging research that named gene control, stress response and epigenetics among them2. These are separate studies by a different group and do not test PCAF-1; they show that the questions the new preprint asks are shared across the field.
Worm findings sometimes move on to mice. The Lapierre Lab, for instance, lists a mouse study published in GeroScience in 2026 that followed earlier worm work on a protein called XPO-12. Whether PCAF-1 research takes a similar path is not addressed in the new preprint.
What to watch next
The next step for this work is peer review, which may bring changes to the data or conclusions. Beyond that, the main open questions follow from the authors’ own claims1:
- whether raising the related KAT2A or KAT2B enzymes changes stress responses, protein clean-up or lifespan in mammals such as mice;
- how large the lifespan effect in worms is, which the full paper may report;
- whether the protection against protein clumping holds up in other disease models;
- whether other labs can repeat the findings.
Biohack will follow this thread if the study is published in a peer-reviewed journal or if new results on these enzymes appear.
